Cibc Private Wealth Group, LLC Hutchmed (China) LTD Transaction History
Cibc Private Wealth Group, LLC
- $51.4 Billion
- Q2 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 67 shares of HCM stock, worth $1,159. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67
Previous 67
-0.0%
Holding current value
$1,159
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding HCM
# of Institutions
65Shares Held
8.25MCall Options Held
3.8KPut Options Held
2.4K-
Schroder Investment Management Group London, X03.02MShares$52.3 Million0.06% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M1.5MShares$26 Million0.04% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.15MShares$19.9 Million0.33% of portfolio
-
Acadian Asset Management LLC Boston, MA389KShares$6.73 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny358KShares$6.19 Million0.0% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.99B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...